1. Home
  2. Downgrades

Downgrades

Nike Stock Turnaround Path Clear, Analyst Says: ‘Getting Back To Winning Takes Time’

Nike Inc (NYSE:NKE) analysts are highlighting the company’s new turnaround plan under CEO Elliott Hill with a focus on inventory, product innovation and wholesale partnerships being key takeaways Friday following the company’s second-quarter financial report. The Nike Analysts: Telsey analyst Cristina Fernández downgraded Nike shares from Outperform to Market Perform and lowered the price target […]

4 Micron Analysts Size Up Q1 Earnings: ‘An Opportunity To Add’?

Micron Technology Inc (NASDAQ:MU) analysts lowered near-term price targets on Thursday following the company’s first-quarter earnings results. Despite the disappointing quarter, analysts generally remain optimistic for the long term, especially in the High-Bandwidth Memory market. Micron Q1 Earnings: Micron reported mixed first-quarter results, beating adjusted earnings estimates of $1.76 per share by 3 cents, but […]

Match Group Analyst Flags Tinder Woes, Industry Challenges For Stock Downgrade

JPMorgan analyst Cory Carpenter downgraded Match Group (NASDAQ:MTCH) from Overweight to Neutral and lowered the price target from $40 to $33. Match is the leading online dating platform with an estimated ~50% share of global dating users across its portfolio of brands. Tinder is the largest and most profitable dating app globally and Hinge is the fastest-growing scaled […]

Getty Images’ AI Uncertainty, FX Headwinds, Premium Valuation Spark Downgrade

JPMorgan analyst Cory Carpenter downgraded Getty Images Holdings (NYSE:GETY) stock from Neutral to Underweight. The stock price declined after the rerating. Getty Images is a leading visual content creator and marketplace that connects over 576,000 content creators with 719,000 purchasing customers. Also Read: Verizon Teams Up With Nvidia To Power AI Apps Over Private 5G […]

JPMorgan Downgrades Editas Medicine, Says Focus Shift Sparks Investor Caution

Editas Medicine Inc. (NASDAQ:EDIT) announced last week a strategic realignment to focus on in vivo gene editing. The shift is designed to optimize costs, extend its cash runway into the second quarter of 2027, and accelerate its progress toward achieving human proof of concept within two years. Also Read: Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts JPMorgan […]

This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. JMP Securities analyst Mitch Germain downgraded Agree Realty Corporation (NYSE:ADC) from Market Outperform to Market Perform. Agree Realty shares closed at $74.05 on Monday. See […]